1fog: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{Theoretical_model}} | {{Theoretical_model}} | ||
[[Image:1fog.png|left|200px]] | [[Image:1fog.png|left|200px]] | ||
{{STRUCTURE_1fog| PDB=1fog | SCENE= }} | {{STRUCTURE_1fog| PDB=1fog | SCENE= }} | ||
===THEORETICAL MODEL STRUCTURE OF ACTINIDIN WITH DIFFERENT BIOLOGICALLY IMPORTANT INHIBITORS=== | ===THEORETICAL MODEL STRUCTURE OF ACTINIDIN WITH DIFFERENT BIOLOGICALLY IMPORTANT INHIBITORS=== | ||
{{ABSTRACT_PUBMED_011009597}} | |||
== | ==Reference== | ||
<ref group="xtra">PMID:011009597</ref><references group="xtra"/> | |||
[[Category: Banerjee, A]] | [[Category: Banerjee, A]] | ||
[[Category: Bhattacharya, S]] | [[Category: Bhattacharya, S]] | ||
Revision as of 13:03, 21 October 2012
![]() |
THEORETICAL MODEL STRUCTURE OF ACTINIDIN WITH DIFFERENT BIOLOGICALLY IMPORTANT INHIBITORSTHEORETICAL MODEL STRUCTURE OF ACTINIDIN WITH DIFFERENT BIOLOGICALLY IMPORTANT INHIBITORS
Template:ABSTRACT PUBMED 011009597
ReferenceReference
- ↑ Oh D, Shin SY, Lee S, Kang JH, Kim SD, Ryu PD, Hahm KS, Kim Y. Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures. Biochemistry. 2000 Oct 3;39(39):11855-64. PMID:11009597